Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine
· Delayed Price · Currency is JOD · Price in USD 3.800
+0.050 (1.33%)
At close: Apr 28, 2026
PEX:BPC Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 104 | 122 | 120 | 120 | 121 | 78 | Upgrade
|
| Market Cap Growth | -7.59% | 2.24% | -0.56% | -0.94% | 56.41% | 6.71% | Upgrade
|
| Enterprise Value | 102 | 120 | 111 | 109 | 111 | 72 | Upgrade
|
| Last Close Price | 2.69 | 3.16 | 3.04 | 3.02 | 2.98 | 1.88 | Upgrade
|
| PE Ratio | 12.31 | 14.44 | 32.54 | 27.70 | 21.51 | 9.07 | Upgrade
|
| PS Ratio | 3.07 | 3.60 | 4.15 | 3.93 | 3.64 | 2.41 | Upgrade
|
| PB Ratio | 1.28 | 1.50 | 1.61 | 1.61 | 1.65 | 1.18 | Upgrade
|
| P/TBV Ratio | 1.28 | 1.51 | 1.62 | 1.62 | 1.67 | 1.19 | Upgrade
|
| P/FCF Ratio | 37461.14 | 43905.27 | 31.03 | 19.18 | 105.72 | 40.29 | Upgrade
|
| P/OCF Ratio | 63.04 | 73.87 | 24.23 | 13.93 | 32.84 | 30.02 | Upgrade
|
| EV/Sales Ratio | 2.99 | 3.52 | 3.85 | 3.55 | 3.34 | 2.23 | Upgrade
|
| EV/EBITDA Ratio | 11.81 | 13.93 | 17.27 | 17.63 | 13.99 | 8.45 | Upgrade
|
| EV/EBIT Ratio | 13.36 | 15.76 | 20.47 | 21.30 | 16.42 | 9.82 | Upgrade
|
| EV/FCF Ratio | 36432.65 | 43002.35 | 28.78 | 17.32 | 97.07 | 37.24 | Upgrade
|
| Debt / Equity Ratio | - | - | - | - | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.11 | 0.17 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.75 | 0.75 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.04 | -0.15 | -0.16 | -0.15 | -0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.39 | -0.39 | -1.71 | -1.98 | -1.37 | -0.98 | Upgrade
|
| Net Debt / FCF Ratio | -1216.30 | -1216.30 | -2.85 | -1.95 | -9.53 | -4.33 | Upgrade
|
| Asset Turnover | 0.36 | 0.36 | 0.32 | 0.35 | 0.40 | 0.43 | Upgrade
|
| Inventory Turnover | 2.48 | 2.48 | 2.20 | 2.22 | 2.53 | 2.36 | Upgrade
|
| Quick Ratio | 4.43 | 4.43 | 4.48 | 6.58 | 7.15 | 6.51 | Upgrade
|
| Current Ratio | 5.44 | 5.44 | 5.45 | 8.22 | 9.01 | 8.31 | Upgrade
|
| Return on Equity (ROE) | 10.82% | 10.82% | 4.94% | 5.90% | 8.08% | 14.10% | Upgrade
|
| Return on Assets (ROA) | 4.98% | 4.98% | 3.76% | 3.62% | 5.08% | 6.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.02% | 9.76% | 7.39% | 7.17% | 9.94% | 12.40% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.40% | 8.40% | 6.60% | 6.10% | 8.30% | 9.80% | Upgrade
|
| Earnings Yield | 8.12% | 6.93% | 3.07% | 3.61% | 4.65% | 11.03% | Upgrade
|
| FCF Yield | 0.00% | 0.00% | 3.22% | 5.21% | 0.95% | 2.48% | Upgrade
|
| Dividend Yield | 1.33% | 1.12% | 1.17% | 1.17% | 2.39% | 1.89% | Upgrade
|
| Payout Ratio | 16.22% | 16.22% | 37.40% | 63.39% | 24.39% | 23.60% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | -2.30% | 2.38% | - | Upgrade
|
| Total Shareholder Return | 1.33% | 1.12% | 1.17% | -1.12% | 4.76% | 1.89% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.